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PURPOSE: Infertility is one of the less common presenting features associated with testicular tumors. We evaluated
the histologic and biochemical findings, and pregnancy outcome in patients presenting with infertility who were found to
have testicular tumors.
METHODS: Seven patients with infertility were found to have testicular cancer over a 15-year period. All patients had
a testicular ultrasound evaluation. The indications for the ultrasound were testicular pain in 2 patients, suspicious palpable
mass in 4, and to rule out the presence of germ cell neoplasia in a patient with carcinoma in situ detected on a previous
biopsy. Physical exam, histological findings, hormonal levels, tumor markers, and pregnancy outcome results were recorded
from the patients medical charts.
RESULTS: Two men had elevated serum follicle stimulant hormone and luteinizing hormone levels, 1 of them had an
abnormally low serum testosterone level. Tumor markers were normal in all patients. In 4 patients the tumor was on the right
side and in 3 on the left. The histological diagnoses were seminoma (n = 5), Leydig cell tumor (n = 1), and carcinoma in situ
(n = 1). Of the 7 patients, 5 underwent adjuvant radiation therapy. Two patients had sperm cryopreserved. Follow up on
fertility status was available in 6 cases. One patient has established a pregnancy and 5 did not achieve a pregnancy after
treatment for their cancer.
CONCLUSIONS: Most of the men who have testicular cancer and male infertility have a seminona. Therefore, men
who present with infertility should be thoroughly investigated to rule out such serious, concomitant diseases along with
their infertility.
DESCRIPTORS: Fertility evaluation. Male infertility. Testis cancer. Testicular neoplasia.
INTRODUCTION
The incidence of testicular cancer
has increased all over the world dur-
ing the last 4 to 5 decades, and in in-
dustrialized countries, testicular
tumors are the most common malig-
nant disease among men aged 20 to 34
years 1,2. While the etiologic causes of
testicular cancer are unknown, a
number of risk factors have been iden-
tified including in situ carcinoma or
invasive carcinoma of the contralateral
testis, cryptorchidism, testicular dys-
genesis, and subfertility 3-7.
A number of reports have sug-
gested a direct correlation between tes-
ticular cancer and infertility8,9. Al-
though a significant number of cancer
patients present with poor pretreat-
ment semen quality, the incidence of
oligospermia or azoospermia in these
patients remains unknown 8,9. Physical
and mental stress, genetic factors, and
hormonal imbalances may all impair
spermatogenesis 2,10-12. As survival rates
improve, the effect of aggressive
therapy on fertility becomes more ap-
parent 13.
Little is known about the inci-
dence, histological features and fertil-
ity outcome of testicular cancer in men
who present for infertility evaluation.
The purpose of the study was to assess
the histologic and biochemical find-
ings, and pregnancy outcome in pa-
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tients undergoing infertility evaluation
who were incidentally diagnosed with
testicular tumors.
MATERIALS AND METHODS
From 1983-1998, 7 men were found
to have undergone infertility evalua-
tions and were diagnosed as having
concurrent testicular cancers. A special-
ist in male infertility (AJT) examined
all patients. Five men had primary, and
two had secondary infertility. Of the 7
patients presenting for fertility evalu-
ation, 2 also had testicular pain, 1 had
history of bilateral cryptorchidism and
2, unilateral cryptorchidism. One pa-
tient underwent a previous orchiec-
tomy due to an undescended testis. Se-
men analyses were performed on all
patients at the first appointment. All
patients underwent a radical orchiec-
tomy. Demographic data, histological
findings, hormonal status, tumor mark-
ers, and pregnancy outcome results
were recorded from their medical
charts.
RESULTS
The mean age of the patients at the
time of diagnosis was 30.7 years (range
25-34) (Table 1). Semen analysis was
evaluated according to the World
Health Organization (WHO) criteria 14.
Semen analysis revealed oligoasthe-
nospermia in 3 patients, azoospermia
in 2, oligospermia in 1, and asthenos-
permia in 1. All patients had a testicu-
lar ultrasound evaluation that demon-
strated a hypoechoic lesion or irregu-
lar intratesticular mass. The only ex-
ception was a man with a previous di-
agnosis of carcinoma in situ, whose
ultrasound revealed no abnormality.
The indications for ultrasound were
testicular pain in 2 patients, suspicious
palpable mass in 4, or rule out the pres-
ence of invasive germ cell neoplasia in
a patient with carcinoma in situ diag-
nosed at a previous testicular biopsy.
Hormonal status and tumor mark-
ers were available in all patients. Two
men had elevated serum follicle stimu-
lant hormone (FSH) and luteinizing
hormone (LH) at the time of fertility
evaluation, and 1 of them had abnor-
mally low serum testosterone levels.
One of these patients had undergone
prior orchiectomy for undescended tes-
tis, and the other patient had an
atrophic testis contralateral to the tes-
tis with cancer. Alpha-feto-protein
(AFP), and human chorionic gonado-
tropin subunit B (B-HCG) were normal
in all men.
In 4 patients, the tumor was located
in the right testis, and in 3, the left (Ta-
ble 2). In the 3 patients who under-
went orchidopexy due to cryp-
torchidism, the cancer was present in
the orchidopexed testis in 2 patients,
and in the contralateral testis in 1. The
pathologic specimen showed invasive
germ cell tumors in 6 patients and
intratubular germ cell neoplasia (car-
cinoma in situ) in 1. All the invasive
germ cell tumors were pT1. The histo-
logical diagnosis of the surgical speci-
men showed seminoma in 5 patients,
Leydig cell tumor in 1, and carcinoma
in situ in 1.
Of the 7 patients, 5 were also
treated with adjuvant radiation therapy
Table 1 - Age, symptoms and hormonal assessment in patients with infertility and testicular cancer.
N Age Symptoms Semen characteristics AFP B HCG FSH LH Testosterone
1 33 Infertility oligoasthenospermia 2.5 2.5 4.5 6.5 532
2 27 Infertility oligospermia 3 2.5 3 5.5 528
3 34 Infertility oligoasthenospermia 2.3 3.5 33 25 138
4 32 Infertility asthenospermia 3.2 4.5 5 6 350
5 33 Testis pain, infertility oligoasthenospermia 1.2 2.5 9 5.5 481
6 25 Testis pain, infertility azoospermia 1.5 4.5 22 15 358
7 31 Infertility azoospermia 1.5 3 9.5 3.2 450
Table 2 - Histological type of cancer, and pregnancy outcome in patients with infertility and testicular cancer.
N Testis Ultrasound Pathology Adjuvant Therapy Pregnancy
1 Right Small intratesticular mass Seminoma Radiation therapy 0
2 Right Hypoechoic mass Seminoma Radiation therapy 1 (ICSI)
3 Right Multiple hypoechoic mass Seminoma Radiation therapy 0
4 Left Hypoechoic mass Seminoma Radiation therapy 0
5 Right Hypoechoic irregular mass Seminoma Radiation therapy 0
6 Left Hypoechoic mass Leydig cell tumor          — ?
7 Left No mass Ca in situ          — 0
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to the para-aortic and ipsilateral com-
mon iliac lymph nodes. All of these
men had a histologic diagnostic of
seminoma. The other 2 patients under-
went radical orchiectomy alone.
Only 2 patients had sperm cryo-
preserved before radiation therapy.
Both patients who cryopreserved their
semen attempted pregnancies with the
use of assisted reproductive tech-
niques (ART), but only one succeded.
The remaining 4 patients who tried to
impregnate their wives through sexual
intercourse alone did not succeed. For
1 patient, the follow up on fertility sta-
tus was not available.
DISCUSSION
In the last 30 years, there has been
increased research on testicular germ
cell cancers 7,15. For all countries, the
incidence showed a substantial up-
ward trend during the period of obser-
vation. The annual increase varied
from 2.3% in Sweden to 5.2% in former
East Germany. If this trend were to
continue, it is postulated that the over-
all incidence of testicular cancer
would double every 15-25 years. Un-
like most cancers that primarily affect
the elderly, germ cell tumors exhibit a
small post-natal peak and a major peak
in the 20-45 year range 16. The major-
ity of these patients are in their repro-
ductive years and may not have started
or completed their families 12,16.
Many studies concerning patients
with testicular cancer indicates that the
majority of them have poor semen
quality before radical orchiectomy 2,17.
It is well documented that testicular
cancer is associated with impaired
spermatogenic function and some pa-
tients already have impairment of Ley-
dig cell function before orchiectomy.
Approximately 50% of patients with
germ cell tumors have sperm concen-
tration below 10 X 106/mL, whereas
the median sperm concentration in the
general population is expected to be
50 X 106/mL or higher 10.
The association between testicular
cancer and poor gonadal function is
very interesting from both an etiologic
and therapeutic point of view 2,10. First,
the increase in the incidence of tes-
ticular cancer has been suggested to
be associated with a general decline in
male reproductive health and it seems
likely that the development of testicu-
lar cancer shares common etiological
factors with other types of testicular
dysfunction. This is supported by the
observation that men with various
types of gonadal dysfunction such as
testicular dysgenesis, androgen insen-
sitivity syndrome, and cryptorchidism
have an increased risk of testicular can-
cer 5,7,15,18-20. In our data, even though
3 patients had cryptorchidism, 4 did
nor have it. Therefore, it might be pos-
sible that the 3 patients with cryp-
torchidism developed testicular cancer
due to the presence of cryptorchidism.
From a therapeutic prospective, be-
cause the cure rate in patients with tes-
ticular cancer exceeds 90%, fertility
aspects need to be addressed in the
management of these men 2,11.
We assessed patients who presented
with infertility and were ultimately di-
agnosed as having testicular cancer.
Infertility is one of the less common
presenting features of testicular cancer.
The possibility that infertility may af-
fect men at high risk for testicular neo-
plasia was first suggested by
Skakkebaek, who described the find-
ing of carcinoma in situ (CIS) in tes-
ticular biopsies from 2 infertile men
who later developed germ cell tumors
7
. In a further study, Skakkebaek et al.
reported CIS in 9 infertile patients, 4
of whom developed invasive tumors
within 5 years 21. The incidence of CIS
in infertile men has been reported as
0.4% to 1.1%. It is estimated that an
invasive growth will develop in 50%
of patients within 5 years of the diag-
nosis 9,18,20. The interval between the
detection of carcinoma in situ and the
diagnosis of an invasive carcinoma
range from 6 months to 9 years. The
types of invasive tumors that can de-
velop include seminoma, embryonal
carcinoma, and teratocarcinoma.
A previous report found an inci-
dence of 230/100,000 cases of testicu-
lar cancer in men seeking infertility
evaluation, higher than that of the age-
matched population (6.74/100,000) 9.
In the past years, we diagnosed testicu-
lar cancer in 6 patients, and carcinoma
in situ in 1 patient who presented for
fertility evaluation. We cannot evalu-
ate the incidence of testicular cancer
in infertile men due to the difficulty
in assessing the number of patients
who sought fertility treatment during
this period of time. The semen analy-
sis of these patients at the time of pres-
entation revealed oligoasthenospermia
in 3, azoospermia in 2, asthenospermia
in 1, and oligospermia in 1. Therefore,
all patients had at least one abnormal-
ity in their semen analysis contribut-
ing to their infertility.
Testicular microlithiasis (TM) has
been considered a benign, non-progres-
sive condition but recent reports have
demonstrated the association between
TM and testicular malignancy 22-24. Al-
though the clinical significance of TM
and the importance of ultrasound
screening for this condition have not
been defined, 30% to 45% of all re-
ported patients with TM had associ-
ated testicular malignancies. In our pa-
tient population, however there were
no patients with microlithiasis diag-
nosed with testicular ultrasound.
In our group of patients, all men
underwent a radical orchiectomy. The
pathologic specimen revealed 6 cases
at stage pT1, and 1 CIS, demonstrat-
ing that all tumors were treated at an
early stage. Of the 7 patients, 5 had
seminoma, 1 had Leydig cell tumor,
and 1 had carcinoma in situ. Although
the management of testicular cancer is
well described, the role of orchiectomy
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in CIS is still debatable. On the other
hand, 50% of men with CIS will de-
velop invasive germ cell cancer. There-
fore, we considered very important to
include in our list of patients with tes-
ticular cancer, the 1 with carcinoma in
situ. All 5 patients with seminoma un-
derwent adjuvant radiation therapy.
Pierek et al. assessed the role of
scrotal ultrasound in the evaluation of
male infertility and found 7 cases of
testicular cancer out of 1,372 subfertile
men 25. In their series, 5 patients had
Leydig cells tumor and 2 had semi-
noma. In our center, ultrasound is not
used routinely to screen subfertile men.
The indications for scrotal ultrasonog-
raphy were testicular pain or abnor-
malities in the physical examination.
Only 2 of our patients chose to
freeze their sperm. It is important to
note that some of these patients under-
went their fertility evaluation more
than 10 years ago, at a time when there
were not available the assisted repro-
ductive techniques (ART) such as in
vitro fertilization (IVF) with intracyto-
plasmic sperm injection (ICSI). Among
the 6 patients in whom follow up was
available, 1 achieved a pregnancy with
ICSI. The remaining 5 never achieved
a pregnancy either through natural in-
tercourse or ART.
It is important, therefore, that all
men with infertility undergo thorough
evaluation to rule out such a serious
concomitant condition. While all of
our patients were treated at an early
stage, it remains to be seen when these
patients would have been diagnosed
with testicular cancer if they had not
been appropriately evaluated. In the
era of ART, when some men are only
asked to give a semen sample and
never examined, this issue cannot be
overemphasized. It is imperative to
obtain a careful history and perform a
thorough physical examination for all
infertile men, irrespective the semen
analysis.
In summary, all 7 of our patients
had an abnormal semen analysis prior
to being diagnosed with testicular
cancer, and 6 of 7 had abnormal find-
ing related to their testicular examina-
tion. Seminomas were the most preva-
lent tumors seen. Men presenting for
infertility investigation should be thor-
oughly evaluated to detect other po-
tentially life-threatening conditions.
RESUMO
PASQUALOTTO FF e col. – Detecção de
câncer de testículo em homens com
infertilidade. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(2):75-80,  2003.
PROPÓSITO: Infertilidade é um
dos padrões incomuns associados com
tumores de testículo. Nós avaliamos os
achados histológicos, bioquímicos, e
gravidez em pacientes com infertili-
dade nos quais foram detectados tumo-
res de testículo.
MÉTODOS: Sete pacientes com
infertilidade nos quais câncer de testí-
culo foi detectado em um período aci-
ma de 15 anos. Todos os pacientes fo-
ram avaliados com ultra-sonografia. As
indicações para ultra-sonografia foram
dor testicular em dois pacientes, sus-
peita de massa palpável em quatro, e
descartar a presença de neoplasia de
células germinativas em um paciente
com carcinoma in situ detectado em
biópsia prévia. Exame físico, achados
histológicos, níveis hormonais, marca-
dores tumorais, e resultados de gravi-
dez foram avaliados nos prontuários
dos pacientes.
RESULTADOS: Dois homens ti-
nham níveis séricos elevados de hormô-
nio folículo-estimulante e hormônio
luteinizante; um destes tinha níveis
anormalmente baixos de testosterona.
Marcadores tumorais estavam normais
em todos os pacientes. Em quatro paci-
entes, o tumor estava localizado no tes-
tículo direito e em três no esquerdo. Os
diagnósticos histológicos foram
seminoma (n = 5), tumor de células de
Leydig (n = 1) e carcinoma in situ (n =
1). Dos sete pacientes, cinco foram sub-
metidos à radioterapia. Dois pacientes
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congelaram seus espermatozóides.
Acompanhamento no estado de fertili-
dade estava disponível em seis pacien-
tes. Um paciente estabeleceu gravidez
e cinco não conseguiram engravidar
após tratamento do câncer.
CONCLUSÕES: A maioria dos ho-
mens com câncer de testículo e infer-
tilidade possui um seminoma. Homens
que se apresentam com infertilidade de-
vem ser cuidadosamente investigados
para descartar doenças concomitantes e
sérias juntamente com a infertilidade.
DESCRITORES: Avaliação da
fertilidade. Infertilidade masculina.
Câncer de testículo. Neoplasia de tes-
tículo.
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